 DUBLIN, April 20, 2021 PRNewswire -- Theravance Biopharma, Inc. NASDAQ: TBPH, a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines, will report its first quarter 2021 financial results and provide a business update after market close on Tuesday, May 4, 2021. An accompanying conference call and simultaneous webcast will be hosted at 5:00 p.m. 